Merck Financial Statements
Merck Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
Merck Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 24,197.7 | 22,636.0 | 22,011.9 |
| Gross Profit ($ mil.) | 18,057.0 | 16,634.9 | 16,862.3 |
| Operating Income ($ mil.) | 440.4 | 3,544.3 | 5,536.6 |
| Total Net Income ($ mil.) | 3,275.4 | 4,433.8 | 4,631.3 |
| Diluted EPS (Net Income) | 1.49 | 2.03 | 2.10 |
Merck Quarterly Statements
| Quarter Ending Mar 08 | Quarter Ending Dec 07 | Quarter Ending Sep 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 5,822.1 | 6,242.9 | 6,074.1 |
| Gross Profit ($ mil.) | 4,584.0 | 4,698.1 | 4,556.3 |
| Operating Income ($ mil.) | 1,581.6 | (3,409.4) | 1,115.1 |
| Total Net Income ($ mil.) | 3,302.6 | (1,630.9) | 1,525.6 |
| Diluted EPS (Net Income) | 1.52 | (0.75) | 0.69 |
Merck Stock Quote & Chart
| 07/03/08 12:00:49 EST •
NYSE •
38.45
•
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Merck Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 3.40 | 3.77 | 1.54 |
| Price/Earnings Ratio | 17.09 | 15.99 | 15.14 |
| Price/Book Ratio | 4.23 | 2.70 | 1.46 |
| Price/Cash Flow Ratio | 7.60 | 11.60 | 9.41 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Merck Financial Ratios
Merck Competitive Intelligence
| Bristol-Myers Squibb | Pfizer | Sanofi-Aventis | |
|---|---|---|---|
| Annual Sales ($ mil.) | 19,348.0 | 48,418.0 | 43,019.0 |
| Employees | 42,000 | 86,600 | 99,495 |
| Market Cap ($ mil.) | 38,848.3 | 118,188.0 | -- |
Competitive Landscape




